Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1 (5-Year IF – 2.0)
Journal Citation Indicator (JCI) (2023) – 0.4
Scopus CiteScore – 3.7 (CiteScore Tracker 3.8)
Index Copernicus  – 171.00; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2023, vol. 32, nr 10, October, p. 1193–1199

doi: 10.17219/acem/171821

Publication type: research letter

Language: English

License: Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Cite as:


Gębska M, Frąszczak M, Dalewski B, Kołodziej Ł. Qualitative and quantitative assessment of headaches in people with temporomandibular joint disorders: A pilot study. Adv Clin Exp Med. 2023;32(10):1193–1199. doi:10.17219/acem/171821

Qualitative and quantitative assessment of headaches in people with temporomandibular joint disorders: A pilot study

Magdalena Gębska1,A,B,C,D, Magdalena Frąszczak2,A,B,C, Bartosz Dalewski3,D,E, Łukasz Kołodziej4,D,F

1 Department of Rehabilitation Musculoskeletal System, Pomeranian Medical University, Szczecin, Poland

2 Student Science Club at the Department of Rehabilitation of Musculoskeletal System, Pomeranian Medical University, Szczecin, Poland

3 Department of Dental Prosthetics, Pomeranian Medical University, Szczecin, Poland

4 Department of Orthopedic Traumatology and Musculoskeletal Oncology, Pomeranian Medical University, Szczecin, Poland

Graphical abstract


Graphical abstracts

Abstract

Background. Headaches (HAs) and temporomandibular joint dysfunction (TMD) are common comorbidities, and the presence of one of them in a patient increases the incidence of the other. The relationship between these 2 conditions may involve common pathophysiological processes. Considering the topicality of the problem, it is justified to conduct research in this field. In this study, we assessed HA type and severity in people with TMD.

Objectives. The aim of the study was to conduct qualitative and quantitative assessments of HAs in people with temporomandibular joint (TMJ) disorders.

Materials and methods. The study group consisted of 51 subjects of both sexes with a TMD diagnosed using the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) test. A self-report questionnaire was utilized to self-assess the presence of TMD symptoms, while the standardized Short-Form of the McGill Pain Questionnaire was used to qualitatively and quantitatively assess HAs.

Results. People with TMD were significantly more likely to report HA occurrences (p < 0.001). Pain intensity was statistically significantly higher among individuals with TMD compared to those without TMD symptoms (p < 0.001). Most often, the HA was associated with a pressing pain (r = 0.82) and least often, it was described as cutting (r = 0.30). Neck and shoulder girdle pain (p = 0.059; 82.9%) and clenching and/or grinding of teeth (p = 0.021; 92.7%) were significantly more common among patients who declared HAs than among those without HAs. The results obtained so far may indicate a significant relationship between HA and TMD.

Conclusions. We have described the relationship between the occurrence of HAs and TMD. Headaches are more frequent and more severe in people with TMD.

Key words: pain, temporomandibular joint, headache, dysfunction, craniofacial pain

Background

According to the World Health Organization (WHO) report, temporomandibular joint disorders (TMDs) are the 3rd most common dental disease after tooth decay and periodontal disease.1 Schiffman et al. states that TMD can affect between 5% and 12% of the world population.2 Some studies have shown a higher prevalence of up to 25% and 33–40% in the general population.3, 4, 5

A study by Chisnoiu et al. indicates that 60–70% of the general population have at least 1 sign of TMD, but only 1 in 4 people with TMD symptoms are referred to specialists.6 In the USA, between 40% and 75% of adults have at least 1 sign of TMD.7 In Korea, the percentage of people with TMD is 3.1% of the adult population, among whom 10.5% had more than 1 symptom related to the presence of this dysfunction.8

Patients with TMD symptoms span a wide age range; however, the peak occurrence is between the ages of 20 and 40.9 Temporomandibular joint disorders affect women 1.5–2.5 times more often than men.9

The etiopathology of TMD is multifactorial and under constant investigation by researchers and clinicians. Genetic conditions, factors located inside the oral cavity, and environmental determinants, with a particular emphasis on psycho-emotional factors, are mentioned as etiological factors.10, 11, 12 The most common symptoms of TMD include, among others, temporomandibular joint (TMJ) mobility disorder, pain in the masticatory muscles and/or TMJ, headaches (HAs), and/or cervical spine pain.13, 14

According to the literature, there is a high rate of comorbidities in patients with multiple chronic pain conditions, including fibromyalgia and HAs.15, 16

The International Classification of Headache Disorders (ICHD-3) published by The International Headache Society (HIS) states that within the facial region of the skull, TMD HAs are the second most common symptom after toothache.17

Headaches have been shown to occur more frequently in patients with TMD symptoms (27.4% compared to 15.2%) and can be divided into 2 main types: primary HAs (migraine and tension-type HA (TTH)) and secondary HAs (e.g., pain attributed to TMD, cervicogenic HA).18, 19 Unlike primary HAs, HAs attributed to TMD have a known cause of pain, which is TMD. The underlying condition of TMD needs to be treated in order to reduce HAs attributed to TMD. There is also a strong correlation between cervical HA and TMD, as patients with TMD often report cervical spine dysfunction, and patients with cervical HA often report TMD symptoms.20, 21

Other studies have shown that TMD patients report HAs more frequently (68–85%) than the general population (50%).22, 23, 24 Aggarwal et al. stated that HAs are more common in patients with TMD symptoms (27.4% compared to 15.2%).25 Other studies have reported that approx. 70% of TMD patients complain of HAs.26 In the study by Ballegaard et al., the incidence of TMD and HA was 56.1%.27 Franco et al. examined 226 patients, and according to their study, TMD and HAs coexist more often compared to a control group without TMD (85.5% compared to 45.6%).28 Reiter et al. observed that the HA attributed to TMD in painful TMD may be related to a central sensitization process.29 In contrast, other studies have found that people with TMD are more likely to suffer from a migraine and episodic TTH.30

Also, Magnusson and Carlsson observed that TMD patients, especially women, suffered from migraines more often than the control group.31 The correlation between TMD and HA was also studied by Gonçalves et al., who confirmed a higher frequency of TMD in the migraine and chronic migraine groups than in the control group.32 This relationship may be associated with increased masticatory muscle tone, which generates nociceptive impulses in the central nervous system, increasing the likelihood of a migraine.32 According to previous scientific studies, migraines are associated with the activation and sensitization of the trigeminal vascular system.32 This leads to the release of several pro-inflammatory neuropeptides and neurotransmitters, and causes a cascade of inflammatory tissue responses, including vasodilation, plasma extravasation secondary to capillary leakage, edema, and mast cell degranulation. It is now believed that neurogenic inflammation contributes to the development of a migraine attack.33, 34 Other researchers have also described a link between HAs and TMD.35, 36, 37, 38

Currently, numerous scientific studies are being carried out in search of innovative methods of HA treatment.39, 40, 41, 42 Also, in the context of TMD, there is more and more new scientific evidence confirming the effectiveness of pharmacological treatment as well as splint therapy and physiotherapy.43, 44

Therefore, it can be assumed with great caution that the coexistence of TMD and HAs may suggest a common pathogenesis, causation, or common confounding factor, although this issue is not fully understood and may seem controversial.45 Therefore, further research on this topic seems justified. In this study, the authors set themselves the goal of assessing the nature of the HAs, their frequency and severity in people with diagnosed disorders of the TMJs.

Objectives

The aim of the study was to conduct qualitative and quantitative assessments of HAs in people with TMJ disorders.

Materials and methods

As described above, HA is a common symptom in people with TMD. The diagnosis of TMD can be difficult, with some controversy regarding the relative importance of clinical and radiological evidence.46 Therefore, it is recommended to use the diagnostic criteria developed by the International Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) Consortium Network and the Orofacial Pain Special Interest Group.46, 47, 48, 49

Our pilot study was conducted between April and September 2022 at the Department of Rehabilitation Musculoskeletal System of the Pomeranian Medical University in Szczecin, Poland. The study group consisted of 51 individuals of both sexes (women: n = 45, 85.5%; men: n = 6, 14.5%), aged 18–35 years, with TMD diagnosed using the RDC/TMD (n = 51, 82.3%).

The inclusion criteria were consent to participate in the study and the absence of neurological, autoimmune, hormonal, and degenerative joint diseases. The exclusion criteria were orthodontic, prosthetic and implant treatment, history of head trauma, condition after head and neck surgery, and pregnancy.

A study involved completing an anonymous questionnaire consisting of 2 parts:

1. An original 17-question survey. The first question – personal data – concerned the gender and age of the respondents. The next questions were related to the occurrence of TMJ symptoms (HA, pain in the neck and shoulder girdle, pain in the masticatory muscles, ear pain, pain in the TMJ, clenching/grinding of teeth, excessive or limited mobility of the jaw, acoustic symptoms, and feeling of increased tension in the masticatory muscles);

2. McGill Pain Questionnaire – Short-Form50, 51, 52 – questions related to the quantitative and qualitative pain assessment. The questionnaire contains 15 adjectives, divided into 2 categories: sensory (adjectives 1–11) and affective (adjectives 12–15), each rated on a 4-point scale of pain severity (pain quality: 0 – not at all; 3 – very much). Furthermore, it includes a visual analog scale (ranging from no pain to the worst possible pain) and an index of the severity of the currently experienced pain (0 – no pain, 10 – unbearable pain). The higher the score, the more severe the patient’s pain.

Statistical analyses

The analysis was performed using the IBM SPSS v. 24 software (IBM Corp., Armonk, USA). Tests included the χ2 tests of independence for comparison of response proportions and one-sample Wilcoxon tests for comparison of pain severity to a null value. If the expected value criterion was not met in the contingency tables, Fisher’s exact test and the Fisher–Freeman–Halton test were applied. Due to the observation of distributions deviating from the normal distribution based on the Shapiro–Wilk test as well as skewness and kurtosis indices, analyses were performed using non-parametric statistical methods.53, 54 Variable statistics are presented in Supplementary Table 1. A threshold of α = 0.05 was used as the level of significance.

Results

The χ2 test was used to compare the proportion of patients with HAs to those who reported no pain. Statistically significant differences have been observed (χ2 = 18.84, degrees of freedom (df) = 1, p < 0.001). Patients with TMD had significantly more HAs, which is confirmed by 80% of respondents (Figure 1).

The type of HA was verified using a one-sample Wilcoxon test due to the fact that patients who declared no HAs at the same time declared a HA frequency of 0. Thus, it was decided to compare the 41 people with HAs to the null value (declared by people with no HAs). The results are presented in Table 1.

Pain severity is statistically significantly higher among individuals with TMD compared to the value of 0, which indicates no pain. Furthermore, almost every type of pain was statistically significantly more frequent compared to the null value, with the exception of cutting pain (p = 0.059), where the average score was close to the value indicating no pain. The obtained difference results (compared to the null value) were moderate for rushing, continuous and intermittent pain (r ≥ 0.30), and strong for other types of pain (r ≥ 0.50, Table 1).

Table 2 shows the results of Fisher’s exact test for the 2×2 tables and the Fisher–Freeman–Halton exact test for larger contingency tables on the comparison of TMD and HA symptom prevalence.

When analyzing the results, it was found that neck and shoulder girdle pain, masticatory muscle pain, ear pain, and TMJ hypermobility, as well as limited mandibular mobility, a feeling of tension in the masticatory muscles, and acoustic complaints, were not differentiated by the perception of a HA. However, TMJ joint blocking was significantly less common among individuals with HAs (68.3%) compared to the group without HAs. In addition, clenching and/or grinding of teeth occurred significantly more frequently among patients with HAs (92.7%, Table 2) compared to the controls.

Discussion

The study performed the quantitative and qualitative assessment of HAs in people with TMD, and did not examine the basis of their occurrence. Patients with TMD declared the presence of HAs significantly more often, which was confirmed by 80% of the respondents. The obtained difference results (compared to the null value) were moderate for continuous (r = 0.49), intermittent (r = 0.46), rushing (r = 0.41), and cutting (r = 0. 30) pain, and were strong for pressing (r = 0.82), persistent (r = 0.66), pickling (r = 0.62), momentary (r = 0.60), dimmed (r = 0.59), blunt (r = 0.51), and breaking pain (r = 0.51).

According to the literature, patients diagnosed with TTH more often described the type of HA they experience as pressing.55, 56 Therefore, at the initial stage of the conducted research, it could have been assumed with great caution that the oppressive type of pain reported by patients with TMD would indicate the presence of TTH, which should be taken into account in future research.

Previous epidemiological studies have shown an association between TMD pain and TTH.55 Clinically, pain associated with TMD and TTH share a combination of distinct head and face signs and symptoms, i.e., tenderness of the masticatory muscles for TMD and pericranial muscle tenderness for TTH in the active phase of both conditions.57 Other clinical intersections between TMD and TTH include the age of subjects in terms of peak incidence, pain severity, pharmacotherapy, and even non-pharmacological treatment.58, 59, 60 A recent study also showed a high prevalence of active myofascial trigger points in TTH patients.61 This finding may support the hypothesis that peripheral muscle mechanisms are involved in the pathophysiology of TTH.

Current research indicates an important role of central sensitization in the pathogenesis of chronic TTH.62 Continuous episodes of pain involving the pericranial muscles (such as the temporalis muscle) can hypersensitize the central nervous system, activating higher brain centers, which can lead to chronic TTH transformation.63 Despite some clinical similarities and overlaps, both TMD HAs and primary TTH HAs are distinct entities.

Other studies have reported that TMD symptoms are more common in individuals with primary HAs compared to those without HAs.64 This relationship is bidirectional, and several studies have shown that most TMD patients report HAs.65 One prospective study claimed that the presence of TMD predicted future HAs.66 In addition, the onset of TMD was followed by an increased incidence of HAs.67 Several randomized controlled trials have shown a beneficial effect of treating the masticatory muscles for HAs.68, 69

The conducted research shows that pain in the masticatory muscles, ear pain, TMJ pain and hypermobility, as well as limited TMJ mobility, the feeling of masticatory muscle tension, and acoustic complaints are not differentiated by the sensation of a HA presence. Pain in the neck and shoulder girdle (82.9%, p = 0.059) as well as clenching and/or grinding of teeth (92.7%, p = 0.021) are significantly more common among patients with both TMD and HAs, which has been confirmed by previous studies. On the other hand, blocking TMJ occurred less frequently in people with HAs than in those without pain. Studies by other authors showed a significant relationship between HAs, TMJ pain and acoustic symptoms. However, in the study by Melo et al., masticatory muscle pain and TMJ pain were found to be more common in patients with HAs. In addition, TMD seems to be more severe in patients with HAs.70 Temporomandibular joint dysfunction is more common in people with HAs than in the pain-free group.71

Limitations

Our preliminary research has some limitations. The main limitation is the small research group, the lack of a neurological examination of patients with HAs, and the lack of additional imaging diagnostics of the TMJs, which should be taken into account when continuing these studies in the future. Further research is needed on the correct diagnosis and causative treatment of patients suffering from HAs resulting from TMD. Patients with suspected primary or secondary HAs due to TMD should be referred to a dental practitioner to ensure effective causative treatment.

Conclusions

According to the conducted pilot studies, HAs are a serious health problem in people with TMD. At the initial stage of the research, it was assumed that TMD patients were more likely to experience a tension HA. Subsequently, it was observed that people with HAs were more likely to have pain in the neck and shoulder girdle, as well as parafunctions such as clenching and/or teeth grinding. In contrast, TMJ blocking occurred significantly less frequently. Therefore, while continuing the research, it is necessary to differentiate TMJ diseases into those of joint and muscle origin. According to research, the treatment of patients with TMD and HAs may require close interdisciplinary cooperation between specialties (dentistry and neurology). Vigilance should be exercised in the differentiation of these 2 disease entities during their treatment.

Supplementary data

The supplementary materials are available at https://doi.org/10.5281/zenodo.8272638. The package contains the following files:

Supplementary Table 1. Descriptive statistics of indicators of tested variables.

Tables


Table 1. The average severity of the headache and type of headache

Dependent variable

Control group (Mdn = 0)

W

Z

p-value

r

Mdn

IQR

Exacerbation of headaches

3.00

1.00

820.00

5.60

<0.001

0.87

Type of pain

pricking

0.00

1.00

171.00

3.94

<0.001

0.62

rushing

0.00

0.00

36.00

2.59

0.010

0.41

pressing

2.00

1.00

595.00

5.18

<0.001

0.82

breaking

0.00

1.75

91.00

3.24

0.001

0.51

cutting

0.00

0.00

10.00

1.89

0.059

0.30

persistent

1.00

1.00

231.00

4.16

<0.001

0.66

blunt

0.00

1.00

91.00

3.24

0.001

0.51

dimmed

0.00

1.00

153.00

3.76

<0.001

0.59

continuous

0.00

1.00

78.00

3.11

0.002

0.49

intermittent

0.00

0.00

45.00

2.89

0.004

0.46

momentary

0.00

1.00

120.00

3.77

<0.001

0.60

W – Wilcoxon test value; Z – standardized test value; r – effect size index of the difference between the obtained value and the null value; IQR – interquartile range; Mdn – median.
Table 2. The relationship between the occurrence of pain and symptoms of temporomandibular joint dysfunction

Current symptom

Control group

Headache

p-value

φ/V

n

%

n

%

Neck and shoulder girdle pain

I don’t know

0

0.0

1

2.4

0.059

0.34

no

5

50.0

6

14.6

yes

5

50.0

34

82.9

Masticatory muscle pain

I don’t know

0

0.0

2

4.9

0.096

0.32

no

5

50.0

7

17.1

yes

5

50.0

32

78.0

Ear pain

I don’t know

0

0.0

4

9.8

0.332

0.25

no

6

60.0

30

73.2

yes

4

40.0

7

17.1

TMJ pain

I don’t know

0

0.0

2

4.9

1.000

0.10

no

3

30.0

12

29.3

yes

7

70.0

27

65.9

TMJ joint blocking

I don’t know

0

0.0

3

7.3

0.034

0.39

no

3

30.0

10

24.4

yes

7

70.0

28

68.3

TMJ hypermobility

I don’t know

1

10.0

7

17.1

0.590

0.14

no

6

60.0

27

65.9

yes

3

30.0

7

17.1

Clenching and/or grinding of teeth

I don’t know

1

10.0

1

2.4

0.021

0.38

no

3

30.0

2

4.9

yes

6

60.0

38

92.7

Limited mandibular mobility

I don’t know

0

0.0

3

7.3

1.000

0.13

no

5

50.0

21

51.2

yes

5

50.0

17

41.5

Acoustic symptoms

no

2

20.0

8

19.5

1.000

0.00

yes

8

80.0

33

80.5

Masticatory muscle tension

no

3

30.0

8

19.5

0.669

0.10

yes

7

70.0

33

80.5

TMJ – temporomandibular joint.

Figures


Fig. 1. The occurrence of headaches in the patients (n = 51)

References (71)

  1. Checherita L, Stamatin O, Liana A, Luca E. Parafunctions in dysfunctional syndrome of the stomatognathic system: Literature review. Rom J Med Dent Educ. 2020;9(1):53–61. https://journal.adre.ro/wp-content/uploads/2020/05/PARAFUNCTIONS-IN-DYSFUNCTIONAL-SYNDROME-OF-THE-STOMATOGNATHIC-SYSTEM-LITERATURE-REVIEW.pdf. Accessed January 3, 2023.
  2. Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applica-tions: Recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache. 2014;28(1):6–27. doi:10.11607/jop.1151
  3. Murphy MK, MacBarb RF, Wong ME, Athanasiou KA. Temporomandibular disorders: A review of etiology, clinical management, and tissue engineering strategies. Int J Oral Maxillofac Implants. 2013;28(6):e393–e414. doi:10.11607/jomi.te20
  4. Aceves-Avila FJ, Chávez-López M, Chavira-González JR, Ramos-Remus C. Temporomandibular joint dysfunction in various rheumatic diseases. Reumatismo. 2013;65(3):126–130. doi:10.4081/reumatismo.2013.126
  5. Calixtre LB, Gruninger BLDS, Chaves TC, Oliveira ABD. Is there an association between anxiety/depression and temporomandibular disorders in college students? J Appl Oral Sci. 2014;22(1):15–21. doi:10.1590/1678-775720130054
  6. Chisnoiu AM, Picos AM, Popa S, et al. Factors involved in the etiology of temporomandibular disorders: A literature review. Med Pharm Rep. 2015;88(4):473–478. doi:10.15386/cjmed-485
  7. Scrivani SJ, Keith DA, Kaban LB. Temporomandibular disorders. N Engl J Med. 2008;359(25):2693–2705. doi:10.1056/NEJMra0802472
  8. Sim SH, Ha M. Association between psychological factors and temporomandibular disorders in Korean adults: The fouth Korean national health and nutritional examination survey (2009). J Korean Soc Dent Hyg. 2013;13(5):739–747. doi:10.13065/jksdh.2013.13.05.739
  9. Bueno CH, Pereira DD, Pattussi MP, Grossi PK, Grossi ML. Gender differences in temporomandibular disorders in adult populational studies: A systematic review and meta-analysis. J Oral Rehabil. 2018;45(9):720–729. doi:10.1111/joor.12661
  10. Valesan LF, Da-Cas CD, Réus JC, et al. Prevalence of temporomandibular joint disorders: A systematic review and meta-analysis. Clin Oral Invest. 2021;25(2):441–453. doi:10.1007/s00784-020-03710-w
  11. Mitrowska-Guźmińska M, Gębska M, Jonko K, et al. Effect of personality type on the occurrence of temporomandibular disorders: A cross-sectional study. Int J Environ Res Public Health. 2022;20(1):352. doi:10.3390/ijerph20010352
  12. Gębska M, Dalewski B, Pałka Ł, Kołodziej Ł, Sobolewska E. Chronotype profile, stress, depression level, and temporomandibular symptoms in students with type D personality. J Clin Med. 2022;11(7):1886. doi:10.3390/jcm11071886
  13. Sagripanti M, Viti C. Primary headaches in patients with temporomandibular disorders: Diagnosis and treatment of central sensitization pain. Cranio. 2018;36(6):381–389. doi:10.1080/08869634.2017.1359353
  14. Liu F, Steinkeler A. Epidemiology, diagnosis, and treatment of temporomandibular disorders. Dent Clin North Am. 2013;57(3):465–479. doi:10.1016/j.cden.2013.04.006
  15. Dao TT, LeResche L. Gender differences in pain. J Orofac Pain. 2000;14(3):169–184; discussion 184–195. PMID:11203754.
  16. Andreu Y, Galdon MJ, Durá E, et al. An examination of the psychometric structure of the Multidimensional Pain Inventory in temporomandibular disorder patients: A confirmatory factor analysis. Head Face Med. 2006;2(1):48. doi:10.1186/1746-160X-2-48
  17. Ambroziak-Kudła K, Kostrzewa-Janicka J. Headaches and TMD patients: Literature review. Prosthodontics. 2023;73(1):81–88. doi:10.5114/ps/162658
  18. Bender SD. Temporomandibular disorders, facial pain, and headaches: May 2012. Headache. 2012;52:22–25. doi:10.1111/j.1526-4610.2012.02134.x
  19. Abouelhuda AM, Kim HS, Kim SY, Kim YK. Association between headache and temporomandibular disorder. J Korean Assoc Oral Maxillofac Surg. 2017;43(6):363. doi:10.5125/jkaoms.2017.43.6.363
  20. Mingels S, Dankaerts W, Granitzer M. Preclinical signs of a temporomandibular disorder in female patients with episodic cervicogenic headache versus asymptomatic controls: A cross‐sectional study. PM R. 2019;11(12):1287–1295. doi:10.1002/pmrj.12156
  21. Piekartz HV, Rösner C, Batz A, Hall T, Ballenberger N. Bruxism, temporomandibular dysfunction and cervical impairments in females: Results from an observational study. Muscoskelet Sci Pract. 2020;45:102073. doi:10.1016/j.msksp.2019.102073
  22. Stovner LJ, Andree C. Prevalence of headache in Europe: A review for the Eurolight project. J Headache Pain. 2010;11(4):289–299. doi:10.1007/s10194-010-0217-0
  23. Van Der Meer HA, Speksnijder CM, Engelbert RHH, Lobbezoo F, Nijhuis-van Der Sanden MWG, Visscher CM. The association between head-aches and temporomandibular disorders is confounded by bruxism and somatic symptoms. Clin J Pain. 2017;33(9):835–843. doi:10.1097/AJP.0000000000000470
  24. Lendraitiene E, Smilgiene L, Petruseviciene D, Savickas R. Changes and associations between cervical range of motion, pain, temporomandibular joint range of motion and quality of life in individuals with migraine applying physiotherapy: A pilot study. Medicina. 2021;57(6):630. doi:10.3390/medicina57060630
  25. Aggarwal VR, McBeth J, Zakrzewska JM, Lunt M, Macfarlane GJ. The epidemiology of chronic syndromes that are frequently unexplained: Do they have common associated factors? Int J Epidemiol. 2006;35(2):468–476. doi:10.1093/ije/dyi265
  26. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808. doi:10.1177/0333102413485658
  27. Ballegaard V, Thede-Schmidt-Hansen P, Svensson P, Jensen R. Are headache and temporomandibular disorders related? A blinded study. Cephalalgia. 2008;28(8):832–841. doi:10.1111/j.1468-2982.2008.01597.x
  28. Franco AL, Gonçalves DAG, Castanharo SM, Speciali JG, Bigal ME, Camparis CM. Migraine is the most prevalent primary headache in individuals with temporomandibular disorders. J Orofac Pain. 2010; 24(3):287–292. PMID:20664830.
  29. Reiter S, Emodi-Perlman A, Kasiel H, et al. Headache attributed to temporomandibular disorders: Axis I and II findings according to the diagnostic criteria for temporomandibular disorders. J Oral Facial Pain Headache. 2021;35(2):119–128. doi:10.11607/ofph.2863
  30. Gonçalves DAG, Camparis CM, Speciali JG, Franco AL, Castanharo SM, Bigal ME. Temporomandibular disorders are differentially associated with headache diagnoses: A controlled study. Clin J Pain. 2011;27(7):611–615. doi:10.1097/AJP.0b013e31820e12f5
  31. Magnusson T, Carlsson GE. Recurrent headaches in relation to temporomandibular joint pain-dysfunction. Acta Odontol Scand. 1978;36(5–6):333–338. doi:10.3109/00016357809029084
  32. Gonçalves MC, Florencio LL, Chaves TC, Speciali JG, Bigal ME, Bevilaqua-Grossi D. Do women with migraine have higher prevalence of temporomandibular disorders? Braz J Phys Ther. 2013;17(1):64–68. doi:10.1590/S1413-35552012005000054
  33. Spekker E, Tanaka M, Szabó Á, Vécsei L. Neurogenic inflammation: The participant in migraine and recent advancements in translational research. Biomedicines. 2021;10(1):76. doi:10.3390/biomedicines10010076
  34. Tanaka M, Török N, Tóth F, Szabó Á, Vécsei L. Co-players in chronic pain: Neuroinflammation and the tryptophan–kynurenine metabolic pathway. Biomedicines. 2021;9(8):897. doi:10.3390/biomedicines9080897
  35. Réus JC, Polmann H, Souza BDM, et al. Association between primary headaches and temporomandibular disorders. J Am Dent Assoc. 2022;153(2):120–131.e6. doi:10.1016/j.adaj.2021.07.021
  36. Greenbaum T, Emodi-Perlman A. Headache and orofacial pain: A traffic-light prognosis-based management approach for the musculoskeletal practice. Front Neurol. 2023;14:1146427. doi:10.3389/fneur.2023.1146427
  37. Wright EF, Clark EG, Paunovich ED, Hart RG. Headache improvement through TMD stabilization appliance and self-management therapies. Cranio. 2006;24(2):104–111. doi:10.1179/crn.2006.017
  38. Glaros A, Urban D, Locke J. Headache and temporomandibular disorders: Evidence for diagnostic and behavioural overlap. Cephalalgia. 2007;27(6):542–549. doi:10.1111/j.1468-2982.2007.01325.x
  39. Tajti J, Szok D, Csáti A, Szabó Á, Tanaka M, Vécsei L. Exploring novel therapeutic targets in the common pathogenic factors in migraine and neuropathic pain. Int J Mol Sci. 2023;24(4):4114. doi:10.3390/ijms24044114
  40. Southey BR, Rodriguez-Zas SL. Alternative splicing of neuropeptide prohormone and receptor genes associated with pain sensitivity was detected with zero-inflated models. Biomedicines. 2022;10(4):877. doi:10.3390/biomedicines10040877
  41. Kleczkowska P, Nowicka K, Bujalska-Zadrozny M, Hermans E. Neurokinin-1 receptor-based bivalent drugs in pain management: The journey to nowhere? Pharmacol Ther. 2019;196:44–58. doi:10.1016/j.pharmthera.2018.11.007
  42. Tanaka M, Török N, Vécsei L. Are 5-HT1 receptor agonists effective anti-migraine drugs? Exp Opin Pharmacother. 2021;22(10):1221–1225. doi:10.1080/14656566.2021.1910235
  43. Dalewski B, Kamińska A, Kiczmer P, et al. Pressure algometry evaluation of two occlusal splint designs in bruxism management: Randomized, controlled clinical trial. J Clin Med. 2021;10(11):2342. doi:10.3390/jcm10112342
  44. Crăciun MD, Geman O, Leuciuc FV, Holubiac IŞ, Gheorghiţă D, Filip F. Effectiveness of physiotherapy in the treatment of temporomandibular joint dysfunction and the relationship with cervical spine. Biomedicines. 2022;10(11):2962. doi:10.3390/biomedicines10112962
  45. Horswell BB, Sheikh J. Evaluation of pain syndromes, headache, and temporomandibular joint disorders in children. Oral Maxillofac Surg Clin North Am. 2018;30(1):11–24. doi:10.1016/j.coms.2017.08.007
  46. Osiewicz M, Lobbezoo F, Loster B, Wilkosz M, Naeije M, Ohrbach R. Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD): The Polish version of a dual-axis system for the diagnosis of TMD.* RDC/TMD Form. J Stomatol. 2013;66(5):576–649. https://protetyka.cm-uj.krakow.pl/cm/uploads/2019/06/JofS_2013_RDC.pdf. Accessed January 5, 2023.
  47. List T, Greene CS. Moving forward with the RDC/TMD. J Oral Rehabil. 2010;37(10):731–733. doi:10.1111/j.1365-2842.2010.02135.x
  48. Petersson A. What you can and cannot see in TMJ imaging: An overview related to the RDC/TMD diagnostic system. J Oral Rehabil. 2010;37(10):771–778. doi:10.1111/j.1365-2842.2010.02108.x
  49. Ohrbach R, Dworkin SF. The evolution of TMD diagnosis: Past, present, future. J Dent Res. 2016;95(10):1093–1101. doi:10.1177/0022034516653922
  50. Bakhtadze MA, Lusnikova IV, Kuzminov KO, Bolotov DA. The Second Short Form of the McGill Pain Questionnaire as the useful additional tool for differential diagnostics of migraine and cervicogenic headache [in Russian]. Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(3):70. doi:10.17116/jnevro202112103170
  51. Adelmanesh F, Jalali A, Attarian H, et al. Reliability, validity, and sensitivity measures of expanded and revised version of the Short-Form McGill Pain Questionnaire (SF-MPQ-2) in Iranian patients with neuropathic and non-neuropathic pain. Pain Med. 2012;13(12):1631–1638. doi:10.1111/j.1526-4637.2012.01517.x
  52. Strand LI, Ljunggren AE, Bogen B, Ask T, Johnsen TB. The Short-Form McGill Pain Questionnaire as an outcome measure: Test-retest reliability and responsiveness to change. Eur J Pain. 2008;12(7):917–925. doi:10.1016/j.ejpain.2007.12.013
  53. George D, Mallery P. IBM SPSS Statistics 27 Step by Step: A Simple Guide and Reference. 17th ed. New York, USA: Routledge; 2022. ISBN:978-1-03-207090-2.
  54. Watkins MW. A Step-by-Step Guide to Exploratory Factor Analysis with SPSS. New York, USA: Routledge; 2021. ISBN:978-0-367-71031-6.
  55. Ashina S, Mitsikostas DD, Lee MJ, et al. Tension-type headache. Nat Rev Dis Primers. 2021;7(1):24. doi:10.1038/s41572-021-00257-2
  56. Scripter C. Headache: Tension-type headache. FP Essent. 2018;473:17–20. PMID:30346680.
  57. Ciancaglini R, Radaelli G. The relationship between headache and symptoms of temporomandibular disorder in the general population. J Dent. 2001;29(2):93–98. doi:10.1016/S0300-5712(00)00042-7
  58. Graff-Radford SB, Newman AC. The role of temporomandibular disorders and cervical dysfunction in tension-type headache. Curr Pain Headache Rep. 2002;6(5):387–391. doi:10.1007/s11916-002-0081-y
  59. Costa Y, Porporatti A, Calderon P, Conti P, Bonjardim L. Can palpation-induced muscle pain pattern contribute to the differential diagnosis among temporomandibular disorders, primary headaches phenotypes and possible bruxism? Med Oral Patol Oral Cir Bucal. 2016;21(1):e59–e65. doi:10.4317/medoral.20826
  60. Neblett R, Cohen H, Choi Y, et al. The Central Sensitization Inventory (CSI): Establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample. J Pain. 2013;14(5):438–445. doi:10.1016/j.jpain.2012.11.012
  61. Fernández-de-las-Peñas C, Cuadrado ML. Physical therapy for headaches. Cephalalgia. 2016;36(12):1134–1142. doi:10.1177/0333102415596445
  62. Do TP, Heldarskard GF, Kolding LT, Hvedstrup J, Schytz HW. Myofascial trigger points in migraine and tension-type headache. J Headache Pain. 2018;19(1):84. doi:10.1186/s10194-018-0913-8
  63. Yu S, Han X. Update of chronic tension-type headache. Curr Pain Headache Rep. 2015;19(1):469. doi:10.1007/s11916-014-0469-5
  64. Bendtsen L, Ashina S, Moore A, Steiner TJ. Muscles and their role in episodic tension-type headache: Implications for treatment. Eur J Pain. 2016;20(2):166–175. doi:10.1002/ejp.748
  65. Gonçalves DAG, Bigal ME, Jales LCF, Camparis CM, Speciali JG. Headache and symptoms of temporomandibular disorder: An epidemiological study. Headache. 2010;50(2):231–241. doi:10.1111/j.1526-4610.2009.01511.x
  66. Anderson GC, John MT, Ohrbach R, et al. Influence of headache frequency on clinical signs and symptoms of TMD in subjects with temple headache and TMD pain. Pain. 2011;152(4):765–771. doi:10.1016/j.pain.2010.11.007
  67. Marklund S, Wiesinger B, Wänman A. Reciprocal influence on the incidence of symptoms in trigeminally and spinally innervated areas. Eur J Pain. 2010;14(4):366–371. doi:10.1016/j.ejpain.2009.06.004
  68. Lim PF, Smith S, Bhalang K, Slade GD, Maixner W. Development of temporomandibular disorders is associated with greater bodily pain experience. Clin J Pain. 2010;26(2):116–120. doi:10.1097/AJP.0b013e3181c507ef
  69. Schokker RP, Hansson TL, Ansink BJ. The result of treatment of the masticatory system of chronic headache patients. J Craniomandib Disord. 1990;4(2):126–130. PMID:2133472.
  70. Hara K, Shinozaki T, Okada-Ogawa A, et al. Headache attributed to temporomandibular disorders and masticatory myofascial pain. J Oral Sci. 2016;58(2):195–204. doi:10.2334/josnusd.15-0491
  71. Melo CEB, Oliveira JLG, Jesus ACF, et al. Temporomandibular disorders dysfunction in headache patients. Med Oral Patol Oral Cir Bucal. 2012;17(6):e1042–e1046. doi:10.4317/medoral.18007